Renal patients often complain of vague abdominal symptoms compatible with a gastric motility disorder. Cisapride is a recently available prokinetic agent that improves motility and emptying of the upper gastrointestinal tract in patients on long-term dialysis. The drug is extensively metabolized in the liver producing metabolites with minimal pharmacologic activity. Adverse reactions are primarily gastrointestinal in nature and include abdominal cramps, flatulence, and diarrhea.
CITATION STYLE
Hubbard, P. M. (1994). Cisapride. ANNA Journal / American Nephrology Nurses" Association, 21(6), 374–375, 380. https://doi.org/10.2460/javma.1995.207.10.1285
Mendeley helps you to discover research relevant for your work.